ChinaDaily Briefs

Daily Brief China: Shanghai Shenzhen CSI 300 Inde, Xingda International, SGX Rubber Future TSR20, MINISO Group Holding , Samvardhana Motherson Automotive Systems Group BV, Sichuan Kelun Pharmaceutical, Meituan and more

In today’s briefing:

  • China’s [Maybe] Biggish [Quasi?] Bazooka
  • Xingda (1899 HK): No Premium Voluntary Conditional Offer to Ward off a Hostile Holder
  • Xingda (1899 HK)’s HK$1.30/Share Offer – Say What?
  • China Opens War Front In Halo Butyl Rubber Trade
  • MINISO Bets Big on Yonghui. Should Investors Be Concerned About the Acquisition?
  • Morning Views Asia: Samvardhana Motherson International Ltd, Wynn Macau Ltd, Yankuang Energy Group
  • Sichuan Kelun Pharmaceutical (002422.CH) – The Real Breakthrough Point in Valuation Is ADC Pipeline
  • Morning Views Asia: Meituan


China’s [Maybe] Biggish [Quasi?] Bazooka

By Travis Lundy

  • Today, in a press conference held jointly by the Governor of the PBOC, the Director of the Financial Regulatory Bureau, and Chairman of the CSRC, China announced market stimulus measures.
  • The PBOC will cut RRR 50bp, the 7-day repo rate 20bp, guide effective mortgage rate cuts, and lower minimum down payments on second homes. There are other commercial RE measures.
  • Three major stock market measures were announced. A RMB500bn collateral swap programme, PBOC backing RMB300bn bank loans for corps to buy stocks, and a Plan to increase Central Huijin investments.

Xingda (1899 HK): No Premium Voluntary Conditional Offer to Ward off a Hostile Holder

By Arun George

  • Xingda International (1899 HK) has disclosed a voluntary conditional offer from Mr Liu Jinlan (Chairman) at HK$1.30 per share, which aligns with the last close price. 
  • The offer is conditional on the offeror and concert parties representing more than 50% of voting rights. The offeror and concert parties represent 37.03% of voting rights.  
  • The offer is a reaction to Mr Zhao Yue’s “hostile” emergence as a substantial shareholder. It is unattractive and will require a bump to satisfy the minimum acceptance condition.   

Xingda (1899 HK)’s HK$1.30/Share Offer – Say What?

By David Blennerhassett

  • After tyre component manufacturer Xingda International (1899 HK) was suspended recently pursuant to the Takeovers Code, an Offer seemed more likely, not another Partial Offer. 
  • On cue, Liu Jinlan, chairman and executive director, plus concert parties (collectively holding 37.03%), have tabled a voluntary conditional Offer (50% acceptance hurdle). But the price? A surprising zero-premium HK$1.30/share
  • However, this Offer is a pre-emptive strike against former employee Yue Zhao, who holds 9.24%; and was recently appointed ED and vice-chairman of Shougang Concord (103 HK), Xingda’s major competitor.

China Opens War Front In Halo Butyl Rubber Trade

By Farah Miller

  • ADD slapped on the US, the EU, the UK, and Singapore imports
  • ADD probe initiated against Canada, Japan and India
  • Russia to be a major beneficiary of the measures

MINISO Bets Big on Yonghui. Should Investors Be Concerned About the Acquisition?

By Devi Subhakesan

  • MINISO‘s  acquisition of a 29.4% stake in the loss-making supermarket chain Yonghui  for USD 890 million has been viewed negatively by investors, leading to a sharp decline in Miniso’s stock.
  • The deal’s size, combined with Yonghui Superstores (601933 CH) unprofitable track record and   MINISO(9896 HK) ‘s unexpected move into the low-margin, highly competitive supermarket space, has likely fueled investor concerns.
  • However, we believe the acquisition provides Miniso with a strategic opportunity for growth and diversification to a sector that remains vital in the offline retail landscape at undemanding valuations.  

Morning Views Asia: Samvardhana Motherson International Ltd, Wynn Macau Ltd, Yankuang Energy Group

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Sichuan Kelun Pharmaceutical (002422.CH) – The Real Breakthrough Point in Valuation Is ADC Pipeline

By Xinyao (Criss) Wang

  • The imagination brought to the market by Kelun’s traditional businesses (infusion business, antibiotics and bulk pharmaceutical chemicals, generic drugs) is not high. So, the only highlight is Kelun-bio’s ADC pipeline.
  • Considering that Kelun has lost pricing power due to VBP, and both Chuanning and Kelun bio have been spun off and listed independently, Kelun’s valuation will not be too high.
  • Our forecast is net profit attributable to shareholders in 2024-2026 is in the range of RMB3-5 billion. Reasonable market value is RMB30-50 billion. Subsidiary Kelun Bio is a better bet.

Morning Views Asia: Meituan

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars